Key result
ECG-only CardioNets achieves ~14% higher diagnostic accuracy than physicians using both ECG and CMR.
Why the study?
CMR provides gold-standard structural and functional insights but is limited by cost and complexity, whereas ECG is accessible but lacks CMR granularity.
Does the CardioNets deep learning framework accurately generate CMR-level functional parameters and synthetic images from 12-lead ECG signals compared to baseline models and human physicians?
Does the CardioNets deep learning framework accurately generate CMR-level functional parameters and synthetic images from 12-lead ECG signals compared to baseline models and human physicians?
CardioNets demonstrates that deep learning can synthesize CMR-level data and images from standard 12-lead ECGs, potentially offering a low-cost, scalable alternative for cardiovascular disease screening.
Answers are grounded in this paper and cite their sources.
May enable ECG-based estimation of CMR metrics in resource-limited settings; leaves open prospective validation before clinical use.
Cardiovascular diseases (CVDs) are the leading cause of global mortality, necessitating accessible and accurate diagnostic tools. While cardiac magnetic resonance imaging (CMR) provides gold-standard insights into cardiac structure and function, its clinical utility is limited by high cost and complexity. In contrast, electrocardiography (ECG) is inexpensive and widely available but lacks the granularity of CMR. We propose CardioNets, a deep learning framework that translates 12-lead ECG signals into CMR-level functional parameters and synthetic images, enabling scalable cardiac assessment. CardioNets integrates cross-modal contrastive learning and generative pretraining, aligning ECG with CMR-derived cardiac phenotypes and synthesizing high-resolution CMR images via a masked autoregressive model. Trained on 159,819 samples from five cohorts, including the UK Biobank (n=42,483) and MIMIC-IV-ECG (n=164,550), and externally validated on independent clinical datasets (n=3,767), CardioNets achieved strong performance across disease screening and phenotype estimation tasks. In the UK Biobank, it improved cardiac phenotype regression R2 by 24.8% and cardiomyopathy AUC by up to 39.3% over baseline models. In MIMIC, it increased AUC for pulmonary hypertension detection by 5.6%. Generated CMR images showed 36.6% higher SSIM and 8.7% higher PSNR than prior approaches. In a reader study, ECG-only CardioNets achieved 13.9% higher accuracy than human physicians using both ECG and real CMR. These results suggest that CardioNets offers a promising, low-cost alternative to CMR for large-scale CVD screening, particularly in resource-limited settings. Future efforts will focus on clinical deployment and regulatory validation of ECG-based synthetic imaging.
No takes yet. Share an insight, caveat, or question.
Ding et al. (2026) studied Cardiovascular diseases (n=163,586). CardioNets (deep learning framework) vs. Baseline models, prior approaches, and human physicians was evaluated on Disease screening and phenotype estimation performance (including AUC, R2, SSIM, PSNR, and diagnostic accuracy). The CardioNets deep learning framework using only ECGs achieved 13.9% higher diagnostic accuracy in a reader study than human physicians using both ECG and real CMR.
Synapse has enriched 10 related papers. Consider them for comparative context: